Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

690 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
How to predict prognosis in early rheumatoid arthritis.
Morel J, Combe B. Morel J, et al. Best Pract Res Clin Rheumatol. 2005 Feb;19(1):137-46. doi: 10.1016/j.berh.2004.08.008. Best Pract Res Clin Rheumatol. 2005. PMID: 15588975 Review.
Outcomes in patients with incipient undifferentiated arthritis.
Morel J, Legouffe MC, Bozonat MC, Sany J, Eliaou JF, Daurès JP, Combe B. Morel J, et al. Joint Bone Spine. 2000 Jan;67(1):49-53. Joint Bone Spine. 2000. PMID: 10773968
Folic acid alters methotrexate availability in patients with rheumatoid arthritis.
Bressolle F, Kinowski JM, Morel J, Pouly B, Sany J, Combe B. Bressolle F, et al. Among authors: morel j. J Rheumatol. 2000 Sep;27(9):2110-4. J Rheumatol. 2000. PMID: 10990220 Clinical Trial.
The down-regulation of HLA-DM gene expression in rheumatoid arthritis is not related to their promoter polymorphism.
Louis-Plence P, Kerlan-Candon S, Morel J, Combe B, Clot J, Pinet V, Eliaou JF. Louis-Plence P, et al. Among authors: morel j. J Immunol. 2000 Nov 1;165(9):4861-9. doi: 10.4049/jimmunol.165.9.4861. J Immunol. 2000. PMID: 11046010
Polymorphism of HLA-DMA and DMB alleles in patients with systemic lupus erythematosus.
Morel J, Simoes Cda S, Avinens O, Sany J, Combe B, Eliaou JF. Morel J, et al. J Rheumatol. 2003 Jul;30(7):1485-90. J Rheumatol. 2003. PMID: 12858445
HLA-DMA*0103 and HLA-DMB*0104 alleles as novel prognostic factors in rheumatoid arthritis.
Morel J, Roch-Bras F, Molinari N, Sany J, Eliaou JF, Combe B. Morel J, et al. Ann Rheum Dis. 2004 Dec;63(12):1581-6. doi: 10.1136/ard.2003.012294. Ann Rheum Dis. 2004. PMID: 15547082 Free PMC article.
Signal transduction pathways: new targets for treating rheumatoid arthritis.
Morel J, Berenbaum F. Morel J, et al. Joint Bone Spine. 2004 Nov;71(6):503-10. doi: 10.1016/j.jbspin.2004.03.004. Joint Bone Spine. 2004. PMID: 15589430 Review.
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt.
Morel J, Audo R, Hahne M, Combe B. Morel J, et al. J Biol Chem. 2005 Apr 22;280(16):15709-18. doi: 10.1074/jbc.M414469200. Epub 2005 Jan 31. J Biol Chem. 2005. PMID: 15684417
On the AJR viewbox. Pseudotumoral colonic tuberculosis complicating rheumatoid arthritis treated with a tumor necrosis factor antagonist.
Lesnik A, Bolivar J, Morel J, Taourel P. Lesnik A, et al. Among authors: morel j. AJR Am J Roentgenol. 2006 Jun;186(6):1799-800. doi: 10.2214/AJR.05.0412. AJR Am J Roentgenol. 2006. PMID: 16714678 No abstract available.
[Rheumatoid arthritis].
Morel J, Combe B. Morel J, et al. Rev Prat. 2006 Mar 15;56(5):553-62. Rev Prat. 2006. PMID: 16729550 French. No abstract available.
690 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback